Adherium Ltd (ADR) - Cash Flow Conversion Efficiency

Latest as of December 2025: 9.437x

Based on the latest financial reports, Adherium Ltd (ADR) has a cash flow conversion efficiency ratio of 9.437x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-7.43 Million ≈ $-5.26 Million USD) by net assets (AU$-787.24K ≈ $-557.02K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Adherium Ltd net asset quality index to measure how much of total assets are equity-financed.

Adherium Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Adherium Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Adherium Ltd to evaluate the quality of earnings relative to operating cash generation.

Adherium Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Adherium Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Platinex Inc
F:9PX
-0.038x
Principal Technologies Inc
V:PTEC
4.320x
Hawsons Iron Ltd
AU:HIO
-0.015x
Motio Ltd
AU:MXO
0.190x
Minrex Resources Ltd
AU:MRR
-0.060x
HOV Services Limited
NSE:HOVS
-0.052x
AB Panevezio Statybos Trestas
STU:YK3
-0.069x
General Engineering Public Company Limited
BK:GEL
0.044x

Annual Cash Flow Conversion Efficiency for Adherium Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Adherium Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see Adherium Ltd (ADR) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$-4.76 Million
≈ $-3.37 Million
AU$-9.98 Million
≈ $-7.06 Million
2.096x +227.98%
2024-06-30 AU$6.48 Million
≈ $4.59 Million
AU$-10.61 Million
≈ $-7.51 Million
-1.638x -62.64%
2023-06-30 AU$9.21 Million
≈ $6.52 Million
AU$-9.28 Million
≈ $-6.56 Million
-1.007x +41.98%
2022-06-30 AU$5.54 Million
≈ $3.92 Million
AU$-9.61 Million
≈ $-6.80 Million
-1.736x -116.08%
2021-06-30 AU$14.04 Million
≈ $9.93 Million
AU$-11.27 Million
≈ $-7.98 Million
-0.803x +62.85%
2020-06-30 AU$3.38 Million
≈ $2.39 Million
AU$-7.32 Million
≈ $-5.18 Million
-2.162x +84.80%
2019-06-30 AU$830.00K
≈ $587.28K
AU$-11.81 Million
≈ $-8.35 Million
-14.225x -1754.91%
2018-06-30 AU$12.81 Million
≈ $9.06 Million
AU$-9.82 Million
≈ $-6.95 Million
-0.767x -50.35%
2017-06-30 AU$22.70 Million
≈ $16.07 Million
AU$-11.58 Million
≈ $-8.19 Million
-0.510x -76.99%
2016-06-30 AU$27.46 Million
≈ $19.43 Million
AU$-7.91 Million
≈ $-5.60 Million
-0.288x -43364.50%
2015-06-30 AU$34.53 Million
≈ $24.43 Million
AU$23.00K
≈ $16.27K
0.001x +100.07%
2014-06-30 AU$2.17 Million
≈ $1.53 Million
AU$-2.16 Million
≈ $-1.53 Million
-0.998x +0.00%
2014-03-31 AU$2.31 Million
≈ $1.64 Million
AU$-2.31 Million
≈ $-1.63 Million
-0.998x -24548.25%
2013-06-30 AU$3.50 Million
≈ $2.48 Million
AU$-14.19K
≈ $-10.04K
-0.004x --

About Adherium Ltd

AU:ADR Australia Medical Devices
Market Cap
$380.23 Million
AU$537.37 Million AUD
Market Cap Rank
#26863 Global
#1266 in Australia
Share Price
AU$0.10
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.20
All Time High
AU$10.31
About

Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides … Read more